LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) earnings date, results and what the price requires
Nasdaq · SEC CIK 0001005286 · SEC filings checked Oct 16, 2026
Next report
Nov 4, 2026
Estimated from reporting history (91-day cycle, SEC 8-K item 2.02 results filings). Not confirmed.
Last close
$6.38
Polygon.io daily close, Oct 16, 2026. End of day, not live.
Trailing diluted EPS
—
Needs four consecutive reported quarters.
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 5, 2026 | $34.2M | $-6.2M | $-0.19 | Filing |
| Mar 31, 2026 | May 6, 2026 | $23.2M | $-15.0M | $-0.43 | Filing |
| Sep 30, 2025 | Nov 6, 2025 | $31.1M | $-10.0M | $-0.29 | Filing |
| May 25, 2025 | Aug 7, 2025 | $36.4M | $-1.1M | $-0.06 | Filing |
| Feb 23, 2025 | Apr 3, 2025 | $35.2M | $-14.8M | $-0.42 | Filing |
| Nov 24, 2024 | Jan 2, 2025 | $32.6M | $-6.6M | $-0.25 | Filing |
| Aug 25, 2024 | Oct 4, 2024 | $24.7M | $-16.2M | $-0.53 | Filing |
| May 26, 2024 | Aug 26, 2024 | $37.9M | $-7.1M | $-0.13 | Filing |
What would LIFECORE BIOMEDICAL, INC. \DE\ have to report for its valuation to change?
Four consecutive reported quarters of diluted EPS are not available in SEC filings. The model is not shown rather than filled with assumptions.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.